Redhill Biopharma Stock Probability Of Bankruptcy
RedHill Biopharma's odds of distress is above 80% at the present time. It has very high probability of going through financial crisis in the upcoming years. RedHill Biopharma's Chance of financial distress is determined by interpolating and adjusting RedHill Altman Z Score to account for off-balance-sheet items and missing or unfiled public information. All items used in analyzing the odds of distress are taken from the RedHill balance sheet, as well as cash flow and income statements available from the company's most recent filings. Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product.
RedHill |
RedHill Biopharma Company chance of financial distress Analysis
RedHill Biopharma's Probability Of Bankruptcy is a relative measure of the likelihood of financial distress. For stocks, the Probability Of Bankruptcy is the normalized value of Z-Score. For funds and ETFs, it is derived from a multi-factor model developed by Macroaxis. The score is used to predict the probability of a firm or a fund experiencing financial distress within the next 24 months. Unlike Z-Score, Probability Of Bankruptcy is the value between 0 and 100, indicating the firm's actual probability it will be financially distressed in the next 2 fiscal years.
More About Probability Of Bankruptcy | All Equity Analysis
Probability Of Bankruptcy | = | Normalized | | Z-Score |
Current RedHill Biopharma Probability Of Bankruptcy | Over 100% |
Most of RedHill Biopharma's fundamental indicators, such as Probability Of Bankruptcy, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, RedHill Biopharma is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Our calculation of RedHill Biopharma probability of bankruptcy is based on Altman Z-Score and Piotroski F-Score, but not limited to these measures. To be applied to a broader range of industries and markets, we use several other techniques to enhance the accuracy of predicting RedHill Biopharma odds of financial distress. These include financial statement analysis, different types of price predictions, earning estimates, analysis consensus, and basic intrinsic valuation. Please use the options below to get a better understanding of different measures that drive the calculation of RedHill Biopharma financial health.
Please note, there is a significant difference between RedHill Biopharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if RedHill Biopharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, RedHill Biopharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party. The Probability of Bankruptcy SHOULD NOT be confused with the actual chance of a company to file for chapter 7, 11, 12, or 13 bankruptcy protection. Macroaxis simply defines Financial Distress as an operational condition where a company is having difficulty meeting its current financial obligations towards its creditors or delivering on the expectations of its investors. Macroaxis derives these conditions daily from both public financial statements as well as analysis of stock prices reacting to market conditions or economic downturns, including short-term and long-term historical volatility. Other factors taken into account include analysis of liquidity, revenue patterns, R&D expenses, and commitments, as well as public headlines and social sentiment.
CompetitionBased on the latest financial disclosure, RedHill Biopharma has a Probability Of Bankruptcy of 100%. This is much higher than that of the sector and significantly higher than that of the Probability Of Bankruptcy industry. The probability of bankruptcy for all United States stocks is notably lower than that of the firm.
RedHill Probability Of Bankruptcy Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses RedHill Biopharma's direct or indirect competition against its Probability Of Bankruptcy to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of RedHill Biopharma could also be used in its relative valuation, which is a method of valuing RedHill Biopharma by comparing valuation metrics of similar companies.RedHill Biopharma is currently under evaluation in probability of bankruptcy category among related companies.
RedHill Fundamentals
| Return On Equity | -246.27 | |||
| Return On Asset | -32.82 | |||
| Profit Margin | (142.81) % | |||
| Operating Margin | (123.49) % | |||
| Current Valuation | 76.08 M | |||
| Shares Outstanding | 234.96 M | |||
| Shares Owned By Insiders | 4.94 % | |||
| Shares Owned By Institutions | 0.20 % | |||
| Price To Earning | (4.01) X | |||
| Price To Book | 0.87 X | |||
| Price To Sales | 3.70 X | |||
| Revenue | 44.49 M | |||
| Gross Profit | 4.03 M | |||
| EBITDA | (50.19 M) | |||
| Net Income | (63.53 M) | |||
| Cash And Equivalents | 34.79 M | |||
| Cash Per Share | 0.93 X | |||
| Total Debt | 85.89 M | |||
| Debt To Equity | 2.99 % | |||
| Current Ratio | 1.80 X | |||
| Book Value Per Share | 0.77 X | |||
| Cash Flow From Operations | (49.74 M) | |||
| Earnings Per Share | (1.80) X | |||
| Number Of Employees | 155 | |||
| Beta | 1.62 | |||
| Market Capitalization | 164.63 M | |||
| Total Asset | 49 M | |||
| Retained Earnings | (82 M) | |||
| Working Capital | 36 M | |||
| Current Asset | 43 M | |||
| Current Liabilities | 7 M | |||
| Z Score | -4.1 |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards RedHill Biopharma in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, RedHill Biopharma's short interest history, or implied volatility extrapolated from RedHill Biopharma options trading.
Currently Active Assets on Macroaxis
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. You can also try the Portfolio Volatility module to check portfolio volatility and analyze historical return density to properly model market risk.
Other Consideration for investing in RedHill Pink Sheet
If you are still planning to invest in RedHill Biopharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the RedHill Biopharma's history and understand the potential risks before investing.
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites |